15 April 2021, at 06:30 – 8:00 EDT / 12:30 – 14:00 CEST
Noncommunicable diseases (NCDs) are on the rise and now make up 7 of the world’s top 10 causes of death. Diabetes is among the top 10 causes of death worldwide, and has increased by 70% since 2000. The number of children and young people living with diabetes is also increasing every year and 1 million now have type 1 diabetes (T1D). However, diabetes commonly goes undiagnosed or is only recognised when life-threatening complications develop. For those who receive a diagnosis, access to insulin remains elusive in many parts of the world. These trends are in contradiction of global political commitments to halt the rise of diabetes deaths by 2025.
On the 14 th April 2021, 100 years since the discovery of insulin, WHO is launching the WHO Global Diabetes Compact. To support this monumental step, strategically selected advocates with lived experiences of diabetes, government representatives and thought leaders representing a variety of stakeholders will feed into a discussion around the opportunities to support implementation of the WHO Global Diabetes Compact and catalyse access to health care services for people living with diabetes of all ages.
This event sought to:
Harness the voices of people living with diabetes and provide an opportunity for a variety of stakeholders to reflect on the content of the WHO Global Diabetes Compact.
Amplify the need to include the needs and perspectives of children and young people in efforts to implement the WHO Global Diabetes Compact.
Identify and share lessons learnt from Government initiatives to improve access to diabetes and NCD prevention and care as a means to support the implementation of the WHO Global Diabetes Compact.
Call for action across stakeholders to support the implementation of the WHO Global Diabetes Compact.
This event was moderated by:
Mr Kyle Jacques Rose, Vice-President, International Diabetes Federation
Dr Mark Barone, Vice-President, International Diabetes Federation;
Dr the Honourable Christopher Tufton, Minister of Health, Jamaica;
Dr Bente Mikkelsen, Director, Department of NCDs, World Health Organization;
Ms Estefania Palomino, Program Officer, The Leona M. and Harry B. Helmsley Charitable Trust;
Ms Jyotsana Rangeen, South East Asia representative, Young Leader in Diabetes, International Diabetes Federation;
Mr Tom Robinson, Co-lead of the Global Project, Juvenile Diabetes Research Foundation;
Mr Jo Jewell, Nutrition Specialist, UNICEF;
Mr Bent Lautrup-Nielsen, Head of Global Development and Advocacy, World Diabetes Foundation;
Dr Ghazi Faisal Sharkas, Assistant to Secretary-General for Primary Healthcare, Ministry of Health, Jordan;
Ms Elizabeth Denyoh, Diabetes Focal Person, Ghana Health Service;
Dr Vindya Kumarapeli, Director of Non-Communicable Diseases, Ministry of Health, Sri Lanka.
Access the recording of the webinar below:
According to the latest IDF estimates, 463 million adults are living with diabetes. Around 90% have type 2 diabetes. An additional 374 million adults live with impaired glucose tolerance, which places them at a higher risk of developing type 2 diabetes later in life.
This webinar featured perspectives from healthcare professionals, institutional representatives and people living with diabetes on the importance of preventing and monitoring impaired glucose tolerance and type 2 diabetes.
Prof Andrew Boulton, IDF President
Dr Mark Barone, IDF VicePresident
Dr Francesco Branca, Director WHO department of Nutrition for Health and Development
Dr Justin Echouffo-Tchuegui, Special Interest Group, John Hopkins
Dr Jacqueline Bowman, OPEN Obesity Platform
Mr Travis Frans, IDF Young Leader in Diabetes living with type 2 diabetes
Dr Erum Ghafoor, IDF Blue Circle Voice member living with type 2 diabetes
Download the webinar agenda and the speaker biographies here.
The slides from the webinar are available here and the webinar report is available here.
Access the recording of the webinar below:
To mark the publication of the IDF-DAR Diabetes and Ramadan Practical Guidelines 2021, the International Diabetes Federation (IDF) and the Diabetes and Ramadan (DAR) International Alliance are hosting a series of regional online workshops in February and March 2021. Registration and participation is free of charge.
February 13 - DAR Francophone - Programme (view recording below)
February 20 - DAR Africa - Programme(view recording below)
February 26 - DAR Middle-East and North Africa - Programme (view recording below)
February 27 - DAR Asia - Programme(view recording below)
February 27 - DAR North America and Caribbean - Programme(view recording below)
March 25 - DAR Europe - Programme (view recording below)
The workshops will address the content of the IDF-DAR Guidelines, developed by leading experts in the field of diabetes and Ramadan, and focus on management recommendations to optimise the care delivered to people with diabetes who plan to fast.
The IDF-DAR Ramadan Guidelines workshops are supported by an unconditional grant from Sanofi and Servier.
DAR Francophone (February 13, 2021)
DAR Africa (February 20, 2021)
DAR Middle-East and North Africa (February 26, 2021)
DAR Asia (February 27, 2021)
DAR North America and Caribbean (February 27, 2021)
Diabetes Care during the COVID-19 era in the IDF North American and Caribbean (NAC) region
30 March, 2021, 16:00 CEST – 10:00 EDT
This webinar, organised by the International Diabetes Federation (IDF) and the Panamerican Health Organization (PAHO), provided an opportunity to learn about the impact that the COVID-19 pandemic has had on diabetes care in North America and the Caribbean.
Health professionals, institutional representatives and people with diabetes presented their different perspectives and discussed how to improve diabetes care in pandemic situations.
This webinar was followed live by 286 live attendees, and included the following speakers:
Dr Timotheus Dorh, Chair, IDF North America and Caribbean region
Dr Anselm Hennis, Director, PAHO/WHO Department on NCDs and Mental Health
Dr Takira Glasgow, physician and diabetologist (Saint Lucia)
Ms Lurline Less, Chair, Diabetes Association of Jamaica
Ms Betsy Rodríguez, nurse and diabetes educator (USA)
Ms Diana Estephanía Novelo Alzina, IDF Young Leader living with type 1 diabetes (Mexico)
Mr Michael Donohoe, IDF Blue Circle Voice living with type 2 diabetes (USA)
Diabetes has been increasing at an alarming rate since the start of the 21st century, driven by health determinants that are largely related to lifestyle changes and their consequences, such as obesity and a sedentary lifestyle. The impact of diabetes has overwhelmed many healthcare systems, particularly those in low and middle-income countries. Reversing the rapid rise in the number of cases and preventing the onset and evolution of diabetes complications should be a common goal.
This is essential to ensure that people who develop diabetes achieve their full life expectancy without compromising their quality of life, while also reducing the economic impact of the condition. A prerequisite to achieving this goal is the ability to measure the distribution of the disease (prevalence and incidence), its determinants (risk factors), and consequences (complications, mortality and health expenditure).
The IDF Guide for Diabetes Epidemiology Studies has been developed to create standardised epidemiological methods in diabetes studies. It will enable researchers to conduct high-quality studies that generate robust data, thereby providing the information needed to develop evidence-based strategies for improving care and strengthening healthcare systems.